首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

2049826

代謝體學市場規模、佔有率、趨勢和預測：按產品、適應症、應用和地區分類，2026-2034年

Metabolomics Market Size, Share, Trends and Forecast by Product, Indication, Application, and Region, 2026-2034

出版日期: 2026年05月01日 | 出版商:

IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2025年全球代謝體學市場價值為32.5億美元，預計2034年將達到76.4億美元，2026年至2034年的複合年成長率為8.91%。對個人化醫療的需求不斷成長、慢性病患病率上升、藥物和生物技術研究不斷擴大，以及對先進生物標記和藥物發現解決方案的需求，都是推動該市場發展的關鍵因素。

代謝體學是生命科學領域的前沿學科，專注於對生物系統中被稱為「代謝物」的小分子化合物進行全面研究。這些代謝物包括醣類、胺基酸、脂質和其他細胞內化合物，並在各種生物過程中發揮至關重要的作用。代謝體學利用質譜和核磁共振波譜等先進的分析技術來鑑定和定量這些代謝物。這有助於深入了解生物體的代謝狀態，並提供有關健康、疾病、藥物反應和環境影響的寶貴資訊。

全球代謝體學市場正經歷強勁成長，這主要得益於其在個人化醫療和健康管理中日益受到重視。代謝體學正成為了解個體獨特代謝特徵的強大工具，從而實現更精準的診斷、治療方法選擇和個人化健康管理方案，進而推動市場成長。此外，慢性病盛行率的上升以及對疾病早期檢測和預防需求的日益成長，也促進了對代謝體學技術的需求，為市場擴張創造了良好的前景。同時，這些能夠識別疾病相關代謝生物標記並實現早期療育和監測的技術的日益普及，也推動了市場成長。此外，不斷擴大的藥物和生物技術研究，以及藥物發現和開發方面的努力，也推動了對代謝體學的需求，以闡明藥物作用機制、預測療效和評估安全性。

代謝體學市場趨勢及促進因素：

個人化醫療的進展

代謝體學市場的主要驅動力之一是個人化醫療日益成長的重要性。醫療保健正逐漸摒棄「一刀切」的模式，而代謝體學在建構針對個別患者的客製化治療方案中發揮著至關重要的作用。這種轉變很大程度上源自於人們日益認知到，僅憑基因變異無法全面了解個體的健康狀況。代謝體學透過捕捉個體代謝譜的動態變化來補充基因組學，從而反映患者對疾病、藥物和環境因素的獨特反應。因此，代謝體學能夠幫助醫療專業人員做出更準確的診斷、選擇個人化治療方法並監測治療反應。例如，在癌症治療中，代謝體學可以識別患者腫瘤內失調的特定代謝通路，從而幫助腫瘤科醫師選擇最有效的治療方法。

慢性病盛行率增加

全球慢性疾病負擔日益加重，包括糖尿病、心血管疾病和肥胖症，是代謝體學市場發展的另一個重要促進因素。代謝體學為疾病的早期檢測、風險評估和監測提供了一種強大的工具。透過分析代謝生物標記物，研究人員和臨床醫生可以識別個別代謝譜中可能在疾病臨床症狀出現之前發生的細微變化。這種早期警報系統對於實施預防措施、在疾病早期階段啟動治療以及追蹤疾病進展至關重要。此外，鑑於生活方式相關因素是導致慢性疾病增加的重要原因，代謝體學可以揭示飲食選擇、身體活動和環境暴露如何影響個體的代謝健康。

藥物和生物技術研究

在製藥和生物技術領域，代謝代謝體學在藥物發現和開發過程中發揮越來越重要的作用。代謝體學能夠深入了解藥物的作用機轉、療效和安全性，進而加速藥物研發進程。研究人員利用代謝體學來識別和檢驗藥物標靶，評估潛在候選藥物的代謝影響，並預測其藥物動力學和毒性。這些資訊有助於簡化藥物開發流程，減少後期研發失敗帶來的高昂成本，並提高創新治療方法上市的可能性。此外，代謝體學對於理解藥物交互作用、最佳化給藥方案以及監測臨床試驗期間的患者反應至關重要，從而提升藥物開發的整體效率和成功率。

The global metabolomics market was valued at USD 3.25 Billion in 2025 and is projected to reach USD 7.64 Billion by 2034, registering a CAGR of 8.91% during 2026-2034.The growing demand for personalized medicine, rising prevalence of chronic diseases, expanding pharmaceutical and biotechnology research, and the need for advanced biomarker and drug discovery solutions are some of the major factors propelling the market.

Metabolomics is a cutting-edge field in the realm of life sciences that focuses on the comprehensive study of small molecules called metabolites within biological systems. These metabolites include substances such as sugars, amino acids, lipids, and other cellular compounds, and they play crucial roles in various biological processes. Metabolomics employ advanced analytical techniques, such as mass spectrometry and nuclear magnetic resonance spectroscopy, to identify and quantify these metabolites. By doing so, it offers insights into an organism's metabolic state, providing valuable information about health, disease, drug responses, and environmental influences.

The global metabolomics market is experiencing robust growth, primarily driven by the growing recognition of the pivotal role that this compound plays in personalized medicine and healthcare. In line with this, metabolomics provides a powerful tool for understanding an individual's unique metabolic profile, enabling more precise diagnosis, treatment selection, and tailored healthcare plans, thereby strengthening the market growth. Moreover, the increasing prevalence of chronic diseases and the need for early disease detection and prevention are boosting demand for metabolomics technologies, creating a positive outlook for market expansion. In addition to this, the widespread adoption of these technologies to identify metabolic biomarkers associated with diseases, facilitating early intervention and monitoring, is contributing to the market's growth. Furthermore, the expansion of pharmaceutical and biotechnology research, coupled with the drive for drug discovery and development, is fueling demand for metabolomics to elucidate drug mechanisms, predict drug efficacy, and assess safety.

Metabolomics Market Trends/Drivers:

Advancements in personalized medicine

One of the foremost drivers of the metabolomics market is the increasing importance of personalized medicine. Healthcare is moving away from a one-size-fits-all approach, and metabolomics plays a pivotal role in tailoring treatments to individual patients. This shift is largely due to the recognition that genetic variations alone do not provide a complete understanding of an individual's health. Metabolomics complements genomics by capturing dynamic changes in an individual's metabolic profile, reflecting their unique response to diseases, drugs, and environmental factors. As a result, metabolomics enables healthcare providers to make more precise diagnoses, select personalized treatment options, and monitor therapeutic responses. For example, in cancer treatment, metabolomics can identify specific metabolic pathways that are dysregulated in a patient's tumor, helping oncologists choose the most effective therapies.

Rising prevalence of chronic diseases

The escalating global burden of chronic diseases including diabetes, cardiovascular disorders, and obesity is another significant driver of the metabolomics market. Metabolomics provides a powerful tool for early disease detection, risk assessment, and monitoring. By analyzing metabolic biomarkers, researchers and clinicians can identify subtle changes in an individual's metabolic profile that may precede the clinical manifestation of a disease. This early warning system is crucial for implementing preventive measures, initiating treatments at the earliest stages of disease development, and tracking disease progression. Additionally, as lifestyle-related factors contribute to the rise in chronic diseases, metabolomics can shed light on how dietary choices, physical activity, and environmental exposures impact an individual's metabolic health.

Pharmaceutical and biotechnology research

The pharmaceutical and biotechnology sectors are increasingly relying on metabolomics to enhance drug discovery and development processes. Metabolomics offers insights into drug mechanisms, efficacy, and safety, thereby accelerating the drug development pipeline. Researchers use metabolomics to identify and validate drug targets, assess the metabolic effects of potential drug candidates, and predict their pharmacokinetics and toxicity. This information helps streamline the drug development process, reduce costly late-stage failures, and improve the chances of bringing innovative therapies to market. Moreover, metabolomics is crucial for understanding drug interactions, optimizing dosing regimens, and monitoring patient responses during clinical trials, contributing to the overall efficiency and success of drug development efforts.

Metabolomics Industry Segmentation:

The publisher provides an analysis of the key trends in each segment of the global metabolomics market report, along with forecasts at the global, regional, and country levels for 2026-2034. Our report has categorized the market based on product, indication, and application.

Breakup by Product:

Metabolomics Instruments
Metabolomics Bioinformatics Tools and Services

Metabolomics bioinformatics tools and services dominate the market

The demand for metabolomics bioinformatic tools and services is mainly propelled by the complexity and volume of data generated in metabolomics research. Metabolomics experiments produce vast datasets with intricate molecular information, making data analysis and interpretation a significant challenge. Besides this, metabolomics bioinformatic tools and services are essential for processing, managing, and extracting meaningful insights from this wealth of data. Furthermore, the integration of multi-omics data, including genomics, proteomics, and metabolomics, is becoming increasingly crucial to gain a holistic understanding of biological systems. To harness the full potential of metabolomics data, researchers require sophisticated software solutions and expert services that can handle data preprocessing, statistical analysis, pathway mapping, and biomarker identification. As metabolomics continues to expand its applications in diverse fields, the demand for bioinformatic tools and services is set to rise, enabling researchers to unlock the valuable information hidden within their datasets.

Breakup by Indication:

Cancer
Cardiovascular Disorders
Neurological Disorders
Inborn Errors of Metabolism
Others

Cancer holds the largest share in the market

The urgent need for more precise and early detection methods, as well as personalized treatment strategies in cancer research and diagnostics is strengthening the demand for metabolomics. They offer a unique advantage in cancer studies by providing a real-time snapshot of an individual's metabolic profile, allowing for the identification of specific metabolic alterations associated with different types and stages of cancer. These metabolic signatures can serve as potential biomarkers for early cancer detection, enabling clinicians to detect malignancies at a more treatable stage. Furthermore, as cancer treatment often leads to metabolic changes and varying responses in patients, metabolomics can assist in tailoring therapeutic approaches by monitoring how a patient's metabolism reacts to specific cancer treatments. This personalized approach has the potential to enhance treatment outcomes and minimize adverse effects, driving the demand for metabolomics applications in the field of oncology.

Breakup by Application:

Biomarker and Drug Discovery
Toxicology
Nutrigenomics
Personalized Medicine
Others

Biomarker and drug discovery dominates the market

The burgeoning demand for metabolomics in biomarker and drug discovery applications is driven by its unparalleled ability to unveil novel biomarkers and therapeutic targets. Metabolomics allows researchers to delve deep into an organism's biochemical landscape, identifying subtle metabolic changes associated with diseases and drug responses that may go unnoticed by other omics techniques. This capability is invaluable in biomarker discovery, where metabolomics can pinpoint specific metabolites indicative of disease presence, progression, or treatment efficacy. Additionally, in drug discovery, metabolomics plays a pivotal role in elucidating drug mechanisms and assessing potential drug candidates' safety profiles by uncovering their metabolic impact. By providing a comprehensive view of the intricate interactions within biological systems, metabolomics accelerates the identification of promising drug targets, expedites the development of new therapies, and minimizes the risk of late-stage drug failures, thereby fueling the demand for metabolomics in these critical areas of research.

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

North America exhibits a clear dominance, accounting for the largest metabolomics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America boasts a thriving biopharmaceutical and healthcare industry, characterized by substantial investments in research and development (R&D). This robust ecosystem fuels the demand for metabolomics technologies in drug discovery and personalized medicine applications, as pharmaceutical companies seek innovative solutions to expedite drug development and enhance patient care. Concurrent with this, the region's healthcare infrastructure places a strong emphasis on precision medicine, with government initiatives and healthcare institutions increasingly recognizing the potential of metabolomics for tailoring treatments and improving patient outcomes. Furthermore, collaborations between academic research institutions and industry players in North America have paved the way for cutting-edge metabolomics research, further propelling the market's growth. These factors, combined with a favorable regulatory environment, position North America as a key hub for metabolomics innovation and adoption, driving the market forward.

Competitive Landscape:

The competitive landscape of the global metabolomics market is dynamic and characterized by intense competition among both established players and emerging companies. Leading companies dominate the market with their comprehensive portfolios of metabolomics instruments, software, and services. These industry giants focus on continuous innovation, strategic partnerships, and acquisitions to expand their market presence and offer integrated solutions to customers. Additionally, academic institutions and research organizations contribute significantly to the market by developing cutting-edge metabolomics technologies and methodologies and fostering collaborations with industry stakeholders. Emerging startups, specializing in niche metabolomics applications, are also gaining traction by introducing innovative tools and services, enhancing competition and driving market growth. Furthermore, the market's global nature makes it highly competitive on a regional basis, with regional players catering to specific geographical preferences and regulations.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided.

Some of the key players in the market include:

Agilent Technologies Inc.
Biocrates Life Sciences AG
Bio-Rad Laboratories Inc.
Bruker Corporation
Danaher Corporation
Human Metabolome Technologies Inc.
Metabolon Inc.
Shimadzu Corporation
Thermo Fisher Scientific Inc.
Waters Corporation

Key Questions Answered in This Report:

How has the global metabolomics market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global metabolomics market?
What is the impact of each driver, restraint, and opportunity on the global metabolomics market?
What are the key regional markets?
Which countries represent the most attractive metabolomics market?
What is the breakup of the market based on the product?
Which is the most attractive product in the metabolomics market?
What is the breakup of the market based on the indication?
Which is the most attractive indication in the metabolomics market?
What is the breakup of the market based on the application?
Which is the most attractive application in the metabolomics market?
What is the competitive structure of the global metabolomics market?
Who are the key players/companies in the global metabolomics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Metabolomics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Metabolomics Instruments
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Metabolomics Bioinformatics Tools and Services
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Indication

7.1 Cancer
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Cardiovascular Disorders
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Neurological Disorders
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Inborn Errors of Metabolism
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by Application

8.1 Biomarker and Drug Discovery
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Toxicology
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Nutrigenomics
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Personalized Medicine
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Competitive Landscape

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
- 13.3.1 Thermo Fisher Scientific Inc.
  - 13.3.1.1 Business Overview
  - 13.3.1.2 Products Offered
  - 13.3.1.2 Business Strategies
  - 13.3.1.4 SWOT Analysis
  - 13.3.1.5 Major News and Events
- 13.3.2 Agilent Technologies Inc.
  - 13.3.2.1 Business Overview
  - 13.3.2.2 Products Offered
  - 13.3.2.2 Business Strategies
  - 13.3.2.4 SWOT Analysis
  - 13.3.2.5 Major News and Events
- 13.3.3 Waters Corporation
  - 13.3.3.1 Business Overview
  - 13.3.3.2 Products Offered
  - 13.3.3.2 Business Strategies
  - 13.3.3.4 SWOT Analysis
  - 13.3.3.5 Major News and Events
- 13.3.4 Bruker
  - 13.3.4.1 Business Overview
  - 13.3.4.2 Products Offered
  - 13.3.4.2 Business Strategies
  - 13.3.4.4 SWOT Analysis
  - 13.3.4.5 Major News and Events
- 13.3.5 Shimadzu Corporation
  - 13.3.5.1 Business Overview
  - 13.3.5.2 Products Offered
  - 13.3.5.2 Business Strategies
  - 13.3.5.4 SWOT Analysis
  - 13.3.5.5 Major News and Events
- 13.3.6 LECO Corporation
  - 13.3.6.1 Business Overview
  - 13.3.6.2 Products Offered
  - 13.3.6.2 Business Strategies
  - 13.3.6.4 SWOT Analysis
  - 13.3.6.5 Major News and Events
- 13.3.7 Metabolon, Inc.
  - 13.3.7.1 Business Overview
  - 13.3.7.2 Products Offered
  - 13.3.7.2 Business Strategies
  - 13.3.7.4 SWOT Analysis
  - 13.3.7.5 Major News and Events
- 13.3.8 Human Metabolome Technologies Inc.
  - 13.3.8.1 Business Overview
  - 13.3.8.2 Products Offered
  - 13.3.8.2 Business Strategies
  - 13.3.8.4 SWOT Analysis
  - 13.3.8.5 Major News and Events

簡介目錄圖表

List of Figures

Figure 1: Global: Metabolomics Market: Major Drivers and Challenges
Figure 2: Global: Metabolomics Market: Sales Value (in Billion USD), 2020-2025
Figure 3: Global: Metabolomics Market: Breakup by Product (in %), 2025
Figure 4: Global: Metabolomics Market: Breakup by Indication (in %), 2025
Figure 5: Global: Metabolomics Market: Breakup by Application (in %), 2025
Figure 6: Global: Metabolomics Market: Breakup by Region (in %), 2025
Figure 7: Global: Metabolomics Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 8: Global: Metabolomics (Metabolomics Instruments) Market: Sales Value (in Million USD), 2020 & 2025
Figure 9: Global: Metabolomics (Metabolomics Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 10: Global: Metabolomics (Metabolomics Bioinformatics Tools and Services) Market: Sales Value (in Million USD), 2020 & 2025
Figure 11: Global: Metabolomics (Metabolomics Bioinformatics Tools and Services) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 12: Global: Metabolomics (Cancer) Market: Sales Value (in Million USD), 2020 & 2025
Figure 13: Global: Metabolomics (Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 14: Global: Metabolomics (Cardiovascular Disorders) Market: Sales Value (in Million USD), 2020 & 2025
Figure 15: Global: Metabolomics (Cardiovascular Disorders) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 16: Global: Metabolomics (Neurological Disorders) Market: Sales Value (in Million USD), 2020 & 2025
Figure 17: Global: Metabolomics (Neurological Disorders) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 18: Global: Metabolomics (Inborn Errors of Metabolism) Market: Sales Value (in Million USD), 2020 & 2025
Figure 19: Global: Metabolomics (Inborn Errors of Metabolism) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 20: Global: Metabolomics (Other Indications) Market: Sales Value (in Million USD), 2020 & 2025
Figure 21: Global: Metabolomics (Other Indications) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 22: Global: Metabolomics (Biomarker and Drug Discovery) Market: Sales Value (in Million USD), 2020 & 2025
Figure 23: Global: Metabolomics (Biomarker and Drug Discovery) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 24: Global: Metabolomics (Toxicology) Market: Sales Value (in Million USD), 2020 & 2025
Figure 25: Global: Metabolomics (Toxicology) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 26: Global: Metabolomics (Nutrigenomics) Market: Sales Value (in Million USD), 2020 & 2025
Figure 27: Global: Metabolomics (Nutrigenomics) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 28: Global: Metabolomics (Personalized Medicine) Market: Sales Value (in Million USD), 2020 & 2025
Figure 29: Global: Metabolomics (Personalized Medicine) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 30: Global: Metabolomics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
Figure 31: Global: Metabolomics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 32: North America: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 33: North America: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 34: United States: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 35: United States: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 36: Canada: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 37: Canada: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 38: Asia Pacific: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 39: Asia Pacific: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 40: China: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 41: China: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 42: Japan: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 43: Japan: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 44: India: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 45: India: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 46: South Korea: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 47: South Korea: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 48: Australia: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 49: Australia: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 50: Indonesia: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 51: Indonesia: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 52: Others: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 53: Others: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 54: Europe: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 55: Europe: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 56: Germany: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 57: Germany: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 58: France: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 59: France: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 60: United Kingdom: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 61: United Kingdom: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 62: Italy: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 63: Italy: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 64: Spain: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 65: Spain: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 66: Russia: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 67: Russia: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 68: Others: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 69: Others: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 70: Latin America: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 71: Latin America: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 72: Brazil: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 73: Brazil: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 74: Mexico: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 75: Mexico: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 76: Others: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 77: Others: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 78: Middle East and Africa: Metabolomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 79: Middle East and Africa: Metabolomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 80: Global: Metabolomics Industry: SWOT Analysis
Figure 81: Global: Metabolomics Industry: Value Chain Analysis
Figure 82: Global: Metabolomics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Metabolomics Market: Key Industry Highlights, 2025 and 2034
Table 2: Global: Metabolomics Market Forecast: Breakup by Product (in Million USD), 2026-2034
Table 3: Global: Metabolomics Market Forecast: Breakup by Indication (in Million USD), 2026-2034
Table 4: Global: Metabolomics Market Forecast: Breakup by Application (in Million USD), 2026-2034
Table 5: Global: Metabolomics Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 6: Global: Metabolomics Market: Competitive Structure
Table 7: Global: Metabolomics Market: Key Players

02-2729-4219

+886-2-2729-4219